lorem ipsum
Get the case study
Adaptive Biotechnologies needed to reach patients when they were presenting with Lyme symptoms, before treatment to participate in their diagnostic study, T-Detect™, in an effort to validate the effectiveness. There was a very short window of time, within a couple of days of having a rash, that patients could enroll in this study.
Curebase deployed a flexible, technology-driven, hybrid site model that allowed Adaptive to recruit patients from specific Lyme-endemic regions where patients were likely to present with suspected Lyme Disease. Read more about how Curebase’s hybrid site model gave this diagnostic study the flexibility to recruit patients both 100% online and through local walk-in clinics.
